胸膜疾患の世界市場レポート 2025年

胸膜疾患市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR7.3％で69億4,000万米ドルに成長します。予測期間における成長の原動力は、胸膜疾患の有病率の増加、高齢化人口の増加、職業上の危険の増加、臨床試験の増加、診断センターの拡大などが見込まれます。予測期間の主な動向としては、診断学および診断ツールの進歩、低侵襲手技の採用、薬剤開発の改善、遠隔医療の採用拡大などが挙げられます。

感染症の流行の高まりは、今後数年間の胸膜疾患市場の成長を牽引すると予想されます。細菌、ウイルス、真菌、寄生虫などの有害な微生物によって引き起こされる感染症は、環境の変化、人間の行動の変化、世界の旅行の進歩などにより、より広まりつつあります。細菌性肺炎、結核、ウイルス感染などの病態は、胸膜腔に炎症、感染、体液貯留を引き起こし、胸膜疾患につながる可能性があります。例えば、2023年1月、国立医学図書館は、感染症が年間5,200万人以上の死亡の原因となっており、世界人口の半数が危険にさらされていると報告しています。さらに、毎年約1,400万人の5歳未満の子供が死亡しており、その70％はワクチン接種で予防できる病気によるものです。感染症の流行が増加するにつれ、胸膜疾患に関連する治療への需要が高まっています。

胸膜疾患市場の企業は、すぐに使用できる注射治療薬の開発に注力しています。これらの調合済み希釈済み薬剤は、投与前に混合や再構成を必要としないため、利便性、正確性、調製時間の短縮が保証されます。例えば、米国の製薬会社Amneal Pharmaceuticalsは2024年4月、初の注射用ペメトレキセドのレディ・トゥ・ユース・バージョンであるPEMRYDI RTUを発売しました。この技術革新は、悪性胸膜中皮腫などの胸膜疾患に対して、再構成の必要性をなくし、調製時間を短縮し、投与ミスを最小限に抑え、効果的な治療へのアクセスを改善することで、利便性の高い治療を提供します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の胸膜疾患PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の胸膜疾患市場：成長率分析
• 世界の胸膜疾患市場の実績：規模と成長, 2019-2024
• 世界の胸膜疾患市場の予測：規模と成長, 2024-2029, 2034F
• 世界の胸膜疾患総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の胸膜疾患市場：疾患タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 胸膜炎
• 胸水
• 肺皮腫
• 中皮腫
• その他の疾患タイプ
• 世界の胸膜疾患市場治療法別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 医薬品
• 胸腔穿刺と胸膜癒着術
• 低侵襲介入
• 外科的介入
• 世界の胸膜疾患市場診断ツール別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 画像技術
• 分子診断
• 胸腔鏡検査
• 胸膜鏡検査
• 世界の胸膜疾患市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院と診療所
• 診断センター
• 調査・学術機関
• 世界の胸膜疾患市場：タイプ別サブセグメンテーション、胸膜炎、実績と予測, 2019-2024, 2024-2029F, 2034F
• 急性胸膜炎
• 慢性胸膜炎
• 感染性胸膜炎
• 非感染性胸膜炎
• 世界の胸膜疾患市場：タイプ別サブセグメンテーション、胸水、実績と予測, 2019-2024, 2024-2029F, 2034F
• 漏出性胸水
• 滲出性胸水
• 悪性胸水
• 肺炎性胸水
• 血胸
• 乳び胸
• 世界の胸膜疾患市場：タイプ別サブセグメンテーション、肺皮腫、実績と予測, 2019-2024, 2024-2029F, 2034F
• 原発性肺皮腫
• 二次性肺皮腫（転移性）
• 局所性肺皮腫
• びまん性肺皮腫
• 世界の胸膜疾患市場：タイプ別サブセグメンテーション、中皮腫、実績と予測, 2019-2024, 2024-2029F, 2034F
• 胸膜中皮腫
• 腹膜中皮腫
• 心膜中皮腫
• 精巣中皮腫
• 世界の胸膜疾患市場：タイプ別サブセグメンテーション、その他の疾患タイプ、実績と予測, 2019-2024, 2024-2029F, 2034F
• 肺塞栓症
• 線維胸郭
• 気胸
• 肺がん
• 結核関連胸膜疾患
• サルコイドーシス

第7章 地域別・国別分析

• 世界の胸膜疾患市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の胸膜疾患市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 胸膜疾患市場：競合情勢
• 胸膜疾患市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bristol Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
  • GSK plc Overview, Products and Services, Strategy and Financial Analysis
  • Astrazeneca plc Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Koninklijke Philips N.V.
• Becton Dickinson and Company
• Boehringer Ingelheim International GmbH
• Sanofi SA
• Penn Medicine
• Henry Ford Health
• Dragerwerk AG
• Emory Healthcare
• Boston Medical Center
• Cook Medical
• WakeMed
• Weill Cornell Medicine
• Fox Chase Cancer Center
• B. Braun SE
• Bicakcilar

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 胸膜疾患市場2029：新たな機会を提供する国
• 胸膜疾患市場2029：新たな機会を提供するセグメント
• 胸膜疾患市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Pleural diseases refer to a group of conditions that affect the pleura, the double-layered membrane surrounding the lungs. These diseases can involve inflammation, infection, or other pathological changes to the pleura. Symptoms of pleural diseases include chest pain, shortness of breath, coughing, and difficulty breathing, and they are often diagnosed using imaging tests such as chest X-rays or CT scans.

The primary types of pleural diseases include pleurisy, pleural effusion, pneumothorax, mesothelioma, and others. Pleurisy, which involves inflammation of the pleura, causes sharp chest pain and is often linked to infections or autoimmune disorders. Treatment options for pleurisy and other pleural diseases include medications, thoracentesis, pleurodesis, minimally invasive procedures, and surgical interventions. Diagnostic methods include imaging techniques, molecular diagnostics, thoracoscopy, and pleuroscopy. These services are commonly provided in hospitals, clinics, diagnostic centers, and research or academic institutions.

The pleural diseases market research report is one of a series of new reports from The Business Research Company that provides pleural diseases market statistics, including the pleural diseases industry's global market size, regional shares, competitors with a pleural diseases market share, detailed pleural diseases market segments, market trends and opportunities, and any further data you may need to thrive in the pleural diseases industry. This pleural diseases market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The pleural diseases market size has grown strongly in recent years. It will grow from $4.86 billion in 2024 to $5.23 billion in 2025 at a compound annual growth rate (CAGR) of 7.6%. The growth observed during the historical period can be attributed to factors such as the rising incidence of pleural effusion, increasing awareness of pleural diseases, a growing focus on early diagnosis, the expanding number of healthcare facilities, and a rise in pleural disease clinical trials.

The pleural diseases market size is expected to see strong growth in the next few years. It will grow to $6.94 billion in 2029 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period is expected to be driven by the increasing prevalence of pleural diseases, the rise in the aging population, a growing number of occupational hazards, an increase in clinical trials, and the expansion of diagnostic centers. Key trends for the forecast period include advancements in diagnostics and diagnostic tools, the adoption of minimally invasive procedures, improved drug development, and the growing adoption of telemedicine.

The rising prevalence of infectious diseases is expected to drive the growth of the pleural diseases market in the coming years. Infectious diseases, caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites, are becoming more widespread due to environmental changes, shifts in human behavior, and advancements in global travel. Conditions such as bacterial pneumonia, tuberculosis, or viral infections can lead to pleural disease by causing inflammation, infection, or fluid buildup in the pleural cavity. For example, in January 2023, the National Library of Medicine reported that infectious diseases are responsible for over 52 million deaths annually, putting half of the global population at risk. Furthermore, approximately 14 million children under the age of five die each year, with 70% of these deaths attributed to diseases that could be prevented through vaccination. As the prevalence of infectious diseases increases, it is driving the demand for treatments related to pleural diseases.

Companies in the pleural diseases market are focusing on developing ready-to-use injectable treatments. These pre-formulated and pre-diluted medications require no mixing or reconstitution before administration, ensuring convenience, accuracy, and reduced preparation time. For instance, in April 2024, Amneal Pharmaceuticals, a US-based pharmaceutical company, launched PEMRYDI RTU, the first ready-to-use version of pemetrexed for injection. This innovation provides a convenient treatment for pleural diseases, such as malignant pleural mesothelioma, by eliminating the need for reconstitution, reducing preparation time, minimizing dosing errors, and improving access to effective therapy.

In October 2023, Aileron Therapeutics, a US-based biopharmaceutical company, acquired Lung Therapeutics for an undisclosed amount. This acquisition enhances Aileron's pipeline with LTI-03 for idiopathic pulmonary fibrosis (IPF) and LTI-01 for loculated pleural effusions (LPEs), further strengthening its focus on orphan pulmonary and fibrosis diseases. Lung Therapeutics, also based in the US, is known for developing innovative peptide drugs targeting fibrosis and rare pulmonary conditions.

Major players in the pleural diseases market are Pfizer Inc., Merck & Co. Inc., Bristol Myers Squibb Company, GSK plc, Astrazeneca plc, Koninklijke Philips N.V., Becton Dickinson and Company, Boehringer Ingelheim International GmbH, Sanofi SA, Penn Medicine, Henry Ford Health, Dragerwerk AG, Emory Healthcare, Boston Medical Center, Cook Medical, WakeMed, Weill Cornell Medicine, Fox Chase Cancer Center, B. Braun SE, Bicakcilar, Redax S.p.a, Rocket Medical.

North America was the largest region in the pleural diseases market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in pleural diseases report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the pleural diseases market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pleural diseases market consist of revenues earned by entities by providing services such as diagnostic, pleurodesis, respiratory therapy, rehabilitation, and biopsy procedures. The market value includes the value of related goods sold by the service provider or included within the service offering. The pleural diseases market also includes sales of antibiotics, chemotherapeutic agents, thoracentesis kits, chest tubes and drainage systems, and pleural biopsy needles. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pleural Diseases Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pleural diseases market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pleural diseases ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pleural diseases market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Disease Type: Pleurisy; Pleural Effusion; Pneumothelioma; Mesothelioma; Other Disease Types
• 2) By Treatment Modalities: Medications; Thoracentesis And Pleurodesis; Minimally Invasive Interventions; Surgical Interventions
• 3) By Diagnostic Tools: Imaging Techniques; Molecular Diagnostics; Thoracoscopy; Pleuroscopy
• 4) By End User: Hospitals And Clinics; Diagnostic Centers; Research And Academic Institutions
• Subsegments:
• 1) By Pleurisy: Acute Pleurisy; Chronic Pleurisy; Infectious Pleurisy; Non-infectious Pleurisy
• 2) By Pleural Effusion: Transudative Pleural Effusion; Exudative Pleural Effusion; Malignant Pleural Effusion; Parapneumonic Pleural Effusion; Hemothorax; Chylothorax
• 3) By Pneumothelioma: Primary Pneumothelioma; Secondary Pneumothelioma (Metastatic); Localized Pneumothelioma; Diffuse Pneumothelioma
• 4) By Mesothelioma: Pleural Mesothelioma; Peritoneal Mesothelioma; Pericardial Mesothelioma; Testicular Mesothelioma
• 5) Other Disease Types: Pulmonary Embolism; Fibrothorax; Pneumothorax; Lung Cancer; Tuberculosis-Related Pleural Disease; Sarcoidosis
• Companies Mentioned: Pfizer Inc.; Merck & Co. Inc.; Bristol Myers Squibb Company; GSK plc; Astrazeneca plc
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pleural Diseases Market Characteristics

3. Pleural Diseases Market Trends And Strategies

4. Pleural Diseases Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Pleural Diseases Growth Analysis And Strategic Analysis Framework

• 5.1. Global Pleural Diseases PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Pleural Diseases Market Growth Rate Analysis
• 5.4. Global Pleural Diseases Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Pleural Diseases Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Pleural Diseases Total Addressable Market (TAM)

6. Pleural Diseases Market Segmentation

• 6.1. Global Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pleurisy
• Pleural Effusion
• Pneumothelioma
• Mesothelioma
• Other Disease Types
• 6.2. Global Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medications
• Thoracentesis And Pleurodesis
• Minimally Invasive Interventions
• Surgical Interventions
• 6.3. Global Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Imaging Techniques
• Molecular Diagnostics
• Thoracoscopy
• Pleuroscopy
• 6.4. Global Pleural Diseases Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Clinics
• Diagnostic Centers
• Research And Academic Institutions
• 6.5. Global Pleural Diseases Market, Sub-Segmentation Of Pleurisy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Acute Pleurisy
• Chronic Pleurisy
• Infectious Pleurisy
• Non-infectious Pleurisy
• 6.6. Global Pleural Diseases Market, Sub-Segmentation Of Pleural Effusion, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Transudative Pleural Effusion
• Exudative Pleural Effusion
• Malignant Pleural Effusion
• Parapneumonic Pleural Effusion
• Hemothorax
• Chylothorax
• 6.7. Global Pleural Diseases Market, Sub-Segmentation Of Pneumothelioma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Primary Pneumothelioma
• Secondary Pneumothelioma (Metastatic)
• Localized Pneumothelioma
• Diffuse Pneumothelioma
• 6.8. Global Pleural Diseases Market, Sub-Segmentation Of Mesothelioma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pleural Mesothelioma
• Peritoneal Mesothelioma
• Pericardial Mesothelioma
• Testicular Mesothelioma
• 6.9. Global Pleural Diseases Market, Sub-Segmentation Of Other Disease Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pulmonary Embolism
• Fibrothorax
• Pneumothorax
• Lung Cancer
• Tuberculosis-Related Pleural Disease
• Sarcoidosis

7. Pleural Diseases Market Regional And Country Analysis

• 7.1. Global Pleural Diseases Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Pleural Diseases Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pleural Diseases Market

• 8.1. Asia-Pacific Pleural Diseases Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pleural Diseases Market

• 9.1. China Pleural Diseases Market Overview
• 9.2. China Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pleural Diseases Market

• 10.1. India Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pleural Diseases Market

• 11.1. Japan Pleural Diseases Market Overview
• 11.2. Japan Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pleural Diseases Market

• 12.1. Australia Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pleural Diseases Market

• 13.1. Indonesia Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pleural Diseases Market

• 14.1. South Korea Pleural Diseases Market Overview
• 14.2. South Korea Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pleural Diseases Market

• 15.1. Western Europe Pleural Diseases Market Overview
• 15.2. Western Europe Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pleural Diseases Market

• 16.1. UK Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pleural Diseases Market

• 17.1. Germany Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pleural Diseases Market

• 18.1. France Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pleural Diseases Market

• 19.1. Italy Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pleural Diseases Market

• 20.1. Spain Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pleural Diseases Market

• 21.1. Eastern Europe Pleural Diseases Market Overview
• 21.2. Eastern Europe Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pleural Diseases Market

• 22.1. Russia Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pleural Diseases Market

• 23.1. North America Pleural Diseases Market Overview
• 23.2. North America Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pleural Diseases Market

• 24.1. USA Pleural Diseases Market Overview
• 24.2. USA Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pleural Diseases Market

• 25.1. Canada Pleural Diseases Market Overview
• 25.2. Canada Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pleural Diseases Market

• 26.1. South America Pleural Diseases Market Overview
• 26.2. South America Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pleural Diseases Market

• 27.1. Brazil Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pleural Diseases Market

• 28.1. Middle East Pleural Diseases Market Overview
• 28.2. Middle East Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pleural Diseases Market

• 29.1. Africa Pleural Diseases Market Overview
• 29.2. Africa Pleural Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Pleural Diseases Market, Segmentation By Treatment Modalities, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Pleural Diseases Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pleural Diseases Market Competitive Landscape And Company Profiles

• 30.1. Pleural Diseases Market Competitive Landscape
• 30.2. Pleural Diseases Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Bristol Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. GSK plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Astrazeneca plc Overview, Products and Services, Strategy and Financial Analysis

31. Pleural Diseases Market Other Major And Innovative Companies

• 31.1. Koninklijke Philips N.V.
• 31.2. Becton Dickinson and Company
• 31.3. Boehringer Ingelheim International GmbH
• 31.4. Sanofi SA
• 31.5. Penn Medicine
• 31.6. Henry Ford Health
• 31.7. Dragerwerk AG
• 31.8. Emory Healthcare
• 31.9. Boston Medical Center
• 31.10. Cook Medical
• 31.11. WakeMed
• 31.12. Weill Cornell Medicine
• 31.13. Fox Chase Cancer Center
• 31.14. B. Braun SE
• 31.15. Bicakcilar

32. Global Pleural Diseases Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pleural Diseases Market

34. Recent Developments In The Pleural Diseases Market

35. Pleural Diseases Market High Potential Countries, Segments and Strategies

• 35.1 Pleural Diseases Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Pleural Diseases Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Pleural Diseases Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer